RallyRaider Posted - 7 hours ago

$AZTR "We are thrilled to announce new preclinical data for our precision dermatology platform that demonstrate proof-of-concept data supporting the use of genetically engineered skin commensals to deliver proteins to the skin,” said Travis Whitfill, Azitra’s co-founder and COO. “These data show the robust preclinical activity of ATR-12 in Netherton syndrome models and further supports the rationale behind our Phase 1b clinical trial in Netherton syndrome patients.” data may 10, lets keep on watch. Looks cheap!

Robere Posted - 04/30/24

$AZTR Amendment entered as of April 29👀

alphaenerji00 Posted - 04/28/24

$AZTR now it is time that this monster awake. Mid of may level of 1 will be reached

INTS915 Posted - 04/26/24

$AZTR , $ 1 coming soon.

SocioCobb Posted - 04/24/24

$AZTR Took profit pre-market this am. Looking for re-entry. Missed my .20 limit today by .004. Oops.

Braverabbit Posted - 04/24/24

$AZTR Plus, Azitra just released data showing a 93% rate response to their compound from people with Netherton's Syndrome. That's Huge. And there are some BP players in Netherton's Syndrome.​ Look up Netherton's Syndrome on Clinicaltrials.gov You'll see some Big Pharma players in Netherton's Syndrome.

Braverabbit Posted - 04/24/24

$AZTR Reminder of one of the reasons you bought AZTR in the first place. The CFO recently made a personal purchase of AZTR stock on 3/29, 47,600 shares of stock. Think the Money Guy may know something? Hint, Azitra already has a collaboration with Bayer in their pipeline and they own a Lot of Azitra stock.​

iRocSevo Posted - 04/23/24

$AZTR loaded up at .22. Target $1.5 (200EMA) good luck all!

Axeknows Posted - 04/23/24

$AZTR the time has come

INTS915 Posted - 04/23/24

$AZTR , $ 1.00 coming soon.

Calderquacks Posted - 04/23/24

$AZTR low risk going long here for a run 🚀

FredDurst Posted - 04/23/24

$AZTR Can Francisco do it again? Stay tuned!

StockMET Posted - 04/23/24

Lot of movers this morning 📈💣⏰ $CYN $PEGY $HWH $AZTR

VrtcIl Posted - 04/23/24

$AZTR is currently achieving new intraday highs, showing a bullish momentum on the technical charts. How far can this thing run guys? Price: 0.24 Float: 2.9M Short Float: 1.2 % 💰 Dollar Volume: 2.0K ℹ️ USA | Biotechnology

SocioCobb Posted - 04/23/24

$AZTR

SocioCobb Posted - 04/22/24

$AZTR Ha... trials are relatively short in duration from start to data. Pre-clinical early? Sure, but not like oncology, etc... rookie.

Rafael_ Posted - 04/22/24

$AZTR Preclinical data is useless. Nowhere near FDA approval

SocioCobb Posted - 04/22/24

$AZTR Nice...

MaseEtch Posted - 04/22/24

$AZTR Alright well my avg is .2625 so if we could just triple that, would be neat

DonCorleone77 Posted - 04/22/24

$AZTR Azitra announces new preclinical data to be presented at ASGCT Azitra "announced preclinical data from the Company's platform and pipeline. The data will be presented on Friday, May 10, 2024, in two oral sessions entitled "Engineered Staphylococcus Epidermidis as a Protein Delivery System for Treating Skin Diseases" and "Staphylococcus epidermidis Strain Expressing LEKTI-D6 for Netherton Syndrome." ATR-12 is an engineered strain of S. epidermidis that expresses a fragment of human lympho-epithelial Kazal-type-related inhibitor (LEKTI) protein, which is missing in patients with Netherton syndrome, a chronic and sometimes fatal disease of the skin estimated to affect approximately one to nine in every 100,000. ATR-12 has been engineered to deliver missing LEKTI protein when applied topically to Netherton syndrome patients. Azitra has an open IND for a Phase 1b clinical trial in adult patients. The data in the abstracts released online today show that topical application of ATR-12 in preclinical models reduced produced reduced IL-36gamma by 93% compared to skin extracts induced to overexpress IL-36gamma. Additionally, topical application of ATR-12 significantly reduced protease activity in skin samples compared to a Netherton syndrome model skin. Finally, ATR-12 produced higher amounts of LEKTI compared to topical application of LEKTI protein alone (6.0 microgram vs. 2.3 microgram, respectively, pless than0.01) after 24 hours and resulted in deeper skin penetration of LEKTI." "We are thrilled to announce new preclinical data for our precision dermatology platform that demonstrate proof-of-concept data supporting the use of genetically engineered skin commensals to deliver proteins to the skin," said Travis Whitfill, Azitra's co-founder and COO. "These data show the robust preclinical activity of ATR-12 in Netherton syndrome models and further supports the rationale behind our Phase 1b clinical trial in Netherton syndrome patients."

Stock_Titan Posted - 04/22/24

$AZTR Azitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy Meeting https://www.stocktitan.net/news/AZTR/azitra-inc-announces-new-preclinical-data-to-be-presented-at-the-ah3m58m78d68.html

SocioCobb Posted - 04/19/24

$AZTR Down Market and Cobb is on the right side of history. I don't typically F with pennies, but I'm building a fatty here. Not many on this one yet. But to the few that are....Godspeed!

SocioCobb Posted - 04/18/24

$AZTR Yes, early stage but from trial(s) to data, time frame is relatively quick... been slowly adding here for weeks.

Stock_Titan Posted - 04/18/24

$AZTR Azitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024 https://www.stocktitan.net/news/AZTR/azitra-inc-to-present-new-data-at-three-upcoming-scientific-7jqpolkjk6sy.html

SocioCobb Posted - 04/18/24

$AZTR Tricky Dick! I'm not fooled....

SocioCobb Posted - 04/18/24

$AZTR Added .189.

BriamFGC Posted - 04/17/24

$AZTR great opportunity to buy and wait for the results like today 🚀🚀🚀

SocioCobb Posted - 04/16/24

$AZTR "And he saith unto them, Why are ye fearful, O ye of little faith? Then he arose, and rebuked the winds and the sea; and there was a great calm."

FredDurst Posted - 04/16/24

$AZTR Did Bayer like what they got? Hopefully

SocioCobb Posted - 04/15/24

$AZTR About damn time. I'm rarely wrong. My patience running thin on this one....